[Forbes.com] The Sovaldi Tax: Gilead Can’t Justify The Price It’s Asking For Hepatitis C Therapy
Jun 18, 2014
A cure for hepatitis C is within reach for 170 million people around the world… Read More
© 2025 CSRXP- All Rights Reserved
News & Highlights
[The Oregonian] Oregon Health Plan Balk at Hepatitis C Drug Coverage
Jun 16, 2014
Eyeing a $168-million annual price tag for two costly new hepatitis C drugs,… Read More
[Vox.com] The fiercest debate in health care is about a $1,000 pill
May 28, 2014
“The people who pay for drugs aren’t fully buying those arguments —… Read More
[Kaiser Health News] ‘National Dialogue’ Urged On Cost Of New Hepatitis C Drug
May 28, 2014
“The outcry continues over the $1,000-a-pill hepatitis C drug made by… Read More
[POLITICO Pulse] NEW COALITION TARGETS SOLVADI COST
May 28, 2014
“A broad coalition of health care groups is trying to compel the… Read More
[POLITICO Pro] 80-group campaign targeting hepatitis drug cost
May 28, 2014
“More than 80 organizations are launching the Campaign for Sustainable Rx… Read More
[CNBC] The $84,000 question: Will focusing on drug prices rein in costs?
May 22, 2014
By Meg Tirrell May 22, 2014 The mounting scrutiny of prescription drug… Read More
[MedPage Today] Medicaid Directors Question Need for $1,000 HCV Pill
May 22, 2014
By Michael Smith May 22, 2014 The evidence base for one of the star… Read More
[Healthcare Payer News] Sovaldi spurs call to action on high drug costs
May 21, 2014
By Anthony Brino May 21, 2014 The breakthrough hepatitis drug Sovaldi… Read More
[Politico] No consensus on how to afford specialty drugs
May 21, 2014
By Brett Norman May 21, 2014 The astronomical price of a new “miracle”… Read More
[Inside Health Policy] Spurred By Sovaldi’s Price, Drug Makers & Plans Consider Mortgaging Pricey Drugs
May 21, 2014
By John Wilkerson May 21, 2014 Spurred by the prospect of Sovaldi’s… Read More
[Reuters] U.S. health insurers say Gilead hepatitis C drug too costly
May 21, 2014
By Bill Berkrot May 21, 2014 The leading U.S. health insurance trade… Read More